<SEC-DOCUMENT>0001493152-23-021812.txt : 20240611
<SEC-HEADER>0001493152-23-021812.hdr.sgml : 20240611
<ACCEPTANCE-DATETIME>20230620131655
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001493152-23-021812
CONFORMED SUBMISSION TYPE:	DRSLTR
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230620

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kindly MD, Inc.
		CENTRAL INDEX KEY:			0001946573
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HEALTH SERVICES [8000]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				843829824
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DRSLTR

	BUSINESS ADDRESS:	
		STREET 1:		5097 SOUTH 900 EAST
		STREET 2:		SUITE 100
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84117
		BUSINESS PHONE:		(385) 388-8220

	MAIL ADDRESS:	
		STREET 1:		5097 SOUTH 900 EAST
		STREET 2:		SUITE 100
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84117
</SEC-HEADER>
<DOCUMENT>
<TYPE>DRSLTR
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="image_001.jpg" ALT="Schedule Appointment with KindlyMD, Inc." STYLE="height: 113px; width: 500px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
20, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Via
Edgar Submission</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
States Securities and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Division
of Corporation Finance</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
of Industrial Application and Services</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100
F Street, N.E.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington,
D.C. 20549</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:
    </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Kindly
    MD, Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Draft
    Registration Statement on Form S-1 </B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Submitted
    May 2, 2023</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CIK
    No. 0001946573</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kindly
MD, Inc. (the &ldquo;Company&rdquo;) provides the following response (the &ldquo;Response Letter&rdquo;) to the comments contained in
the letter (the &ldquo;Comment Letter&rdquo;) of the staff of the Division of Corporation Finance (the &ldquo;Staff&rdquo;) of the U.S.
Securities and Exchange Commission (the &ldquo;Commission&rdquo;) dated May 26, 2023, relating to the above-referenced filing of the
Draft Registration Statement on Form S-1 (the &ldquo;DRS&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
response to the following enumerated comments in the Comment Letter, we respectfully submit the following responses:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Draft
    Registration Statement on Form S-1 submitted May 2, 2023</U></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cover
    Page</U></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    note that each unit being offered includes two warrants that are immediately exercisable. Please note that the shares underlying
    these warrants must be registered on this registration statement. Please amend the cover page caption to clarify the number of shares
    that you are registering that underlie the warrants. Please see Securities Act CDI 139.01.</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have updated the cover page of the Draft Registration Statement (&ldquo;DRS&rdquo;) per your request and will include the exact
    number of shares underlying the warrants in a later amendment once those amounts have been determined.</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    note your disclosure that you &ldquo;may&rdquo; be a controlled company under Nasdaq listing standards and that your CEO, Tim Pickett,
    beneficially owns 73% of your common stock.</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    revise your cover page and the related risk factor to disclose that you are a controlled company, identify Mr. Pickett as your controlling
    shareholder and the amount of voting power the controlling stockholder will own following the completion of the offering.</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
We have updated the cover page and the Risk Factors on page 16 per your request.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    revise your cover page to clarify that the Non-tradeable warrant will not be listed on the Nasdaq Capital Market.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have updated the cover page of the DRS per your request.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Prospectus
    Summary, page 5</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    note that your summary appears to only discuss the positive aspects of the Company. The prospectus summary should provide a brief,
    but balanced, description of the key aspects of the Company as of the latest practicable date. Please revise the summary to also
    discuss any negative aspects of the Company`s experience, strategy, and prospects. For example only and without limitation, please
    revise the prospectus summary to provide:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    brief description of the regulatory approvals that are required for your products;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    uncertainty related to laws and regulations affecting the medical marijuana industry; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    substantial doubt related to your ability to continue as a going concern, and your history of net losses and accumulated deficit.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have revised the DRS to reflect your comment. Please see pages 5, 6 and 11 of the amendment.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    note your statement on page 6 that you intend to expand into five additional markets in 2023 through expansion of clinic locations
    and additional acquisitions. We also note your statement on page 34 that you &ldquo;hope to be able to enter four new markets in
    the twelve calendar months following the closing of the Offering.&rdquo; Please clarify and provide more detail regarding your plans
    related to your expansion goals, including a brief description of the types of opportunities you intend to explore, the markets that
    you intend to expand into in 2023/2024, whether you have taken any steps to expand into these markets, and whether you have identified
    any additional clinic locations or acquisitions or entered into any agreements or commitments for any material acquisitions or investments.
    If you do not have definitive plans at this time, revise to include balancing disclosure to clarify that your plans are in the early
    stages of development and that you do not currently have agreements in place for expansions or acquisitions.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    Thank you for your comment. We have revised the DRS to include these disclosures; please see page 5-6 and 31-34 of the amendment.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    provide your basis to support the following statements:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    page 5, your statement that you anticipate the expansion into the Murray office space would increase your revenue opportunity by
    up to $270,000 per month in the summer of 2023.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    pages 6, 35 and 42 &ldquo;KindlyMD is one of the largest providers of medical evaluation and management services related to treatment
    recommendations within the medical cannabis program in Utah.&rdquo;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    page 34, &ldquo;Creating standard workflows based on provider/patient interaction can be both art and science and may yield new processes
    that could improve patient outcomes in relation to the opioid epidemic in the United States.&rdquo;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
We have revised the statement on page 5 to remove the specific date and amount of revenue. We have modified the statement on page 34
to include further information about this process. Additionally, regarding the size of the Company referenced on pages 6, 35 and 42,
we refer to this April monthly report from the State of Utah (see https://medicalcannabis.utah.gov/wp-content/uploads/April-Monthly-Report.pdf)
that states there are 70,000 patients in Utah. The Company treats 14,800 of these patients, making up 21% of the market share. We
have updated the language on page 5 and 39 of the DRS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Risk
    Factors, page 10</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Several
    of the risk factors in this section are duplicative. Please revise to eliminate redundancy.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have revised the Risk Factors section per your comment. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    note that several risk factors refer to &ldquo;Subordinate Voting Shares,&rdquo; but you neither appear to be offering any such shares,
    nor do you appear to discuss these shares elsewhere in the prospectus. Please clarify or modify your disclosure accordingly.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We appreciate your comment and have updated the DRS to reflect this comment and remove references to &ldquo;Subordinate Voting
    Shares&rdquo;.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>The
    market price for the Common Shares may be volatile, which may affect the price at which you could sell the Subordinate Voting Shares,
    page 20</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    note recent instances of extreme stock price run-ups followed by rapid price declines and stock price volatility seemingly unrelated
    to company performance following a number of recent initial public offerings, particularly among companies with relatively smaller
    public floats. Revise to disclose such and state that such volatility, including any stock-run up, may be unrelated to your actual
    or expected operating performance and financial condition or prospects, making it difficult for prospective investors to assess the
    rapidly changing value of your stock.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have added this language into the risk factor section. Please see page 20.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cautionary
    Note Regarding Forward-Looking Statements, page 24</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    note your statements on pages 22 and 23 that investors &ldquo;should not place undue reliance&rdquo; on forward-looking statements.
    We also note your statement cautioning investors not to give undue weight to estimates and projections and your statement that you
    have not independently verified the statistical and other industry data generated by independent parties. These statements imply
    that investors are not entitled to rely on the information included in the registration statement and imply a disclaimer of responsibility
    for this information in the registration statement. Please either revise this section to remove such implication or specifically
    state that you are liable for all information in the registration statement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
We have updated the DRS per your comment and amended the forward-looking statements language.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    note your references to forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Please
    be advised that the safe harbor for forward-looking statements is inapplicable in this context, because you are not currently a reporting
    company. See Section 27A(a)(1) of the Securities Act. Therefore, please either delete all references to the Private Securities Litigation
    Reform Act or make it clear that the safe harbor does not apply to this offering.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have updated the DRS per your comment and have deleted references to the Private Securities Litigation Reform Act.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Use
    of Proceeds, page 25</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    note your disclosure that you intend to use the net proceeds from this offering for general corporate purposes, including capital
    expenditures and real estate. Please revise to provide more meaningful and specific disclosure of the intended use of proceeds, with
    respect to any particular capital expenditures that you expect to make. For example, we note that you hope to acquire five to ten
    clinics in 2023/2024 and your plan to enter four new markets in the twelve calendar months following the closing of the Offering
    &ldquo;[a]s funding is secured or made available.&rdquo; If any of the proceeds of this offering will be used, either directly or
    indirectly, to finance these acquisitions, expand your disclosure in this section to identify such businesses, if known, or, if not
    known, identify the nature of the businesses to be sought, the status of any negotiations with respect to the acquisition, and provide
    a brief description of such business. Refer to Instruction 6 to Item 504 of Regulation S-K for guidance.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have revised the Use of Proceeds section to include more detailed descriptions of the proposed use of funds based on the amounts
    raised in the Offering. Please see our changes on Page 23. The exact amount included in each Use of Proceeds category and the
    allocation of the amounts of each category will be determined at a later date and included in an subsequent amendment.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Business
    Revenue Streams</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Data
    Collection and Research, page 30</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">So
    that investors may better understand the data collection part of your business, describe your data acquisition and analysis processes.
    For example, please disclose your informed consent procedures, the method by which you obtain the data, the nature of the data, and
    how data collection is used to improve your products and marketing efforts, providing examples where useful to investors. Please
    also provide more information regarding your artificial intelligence technology, including its development, the nature of the predictions
    and inferences it generates. To the extent you have agreements with third party vendors or software developers, please provide a
    discussion of those agreements and their material terms, and file them as exhibits. Last, clarify whether you generate revenues from
    data collection and research. We note your discloser on page F-6.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have revised and updated the Data Collection and Research section, per your request. Please see pages 31 and 38.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Plan
    of Operation, page 34</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    expand your disclosure to state whether any specific government funding programs have materially impacted your operating results
    or liquidity in any of the periods presented. If so, disclose the status of those programs and whether you expect a similar material
    impact in future periods.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have revised the section on government funding per your request. Please see page 33.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regarding
    your acquisition growth strategy, please disclose whether you have identified any specific acquisition targets and the status of
    those negotiations, if material.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have updated the acquisition growth strategy section disclosure per your request. Please see pages 5 and 33 of the DRS.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Operating
    Expenses, page 36</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    expand your disclosure to quantify the specific costs increases that caused your G&amp;A expenses to increase from 34% of sales in
    2021 to 57% of sales in 2022. Clarify why your &ldquo;additional investments in infrastructure and technology&rdquo; were not capitalized.
    Similarly, please expand your personnel expense disclosure to explain why these costs increased from 60% of sales in 2021 to 110%
    of sales in 2022. Explain why these costs increased by a substantially greater rate than sales and whether you expect this trend
    to continue. Specifically discuss the circumstances surrounding the $1.6 million equity based compensation expense referenced on
    page F-5 and its impact on your operating results. See Item 303(a) of Regulation S-K.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have revised the &ldquo;Operating Expenses&rdquo; section as instructed on Page 33 and 24.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Revenue,
    page 36</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    expand your disclosure to specifically describe the factors that materially impacted your 51% revenue variance. For example, if the
    variance was materially impacted by an increase in non-opioid treatment appointments then please quantify the increase in
    appointments. Disclose whether there was a material change in pricing between 2021 and 2022. Quantify the portion of total revenue
    comprised by your controlled substance medication services. Describe any known trends or uncertainties that have had or that are
    reasonably likely to have a material favorable or unfavorable impact on net sales or revenues. See Item 303(b)(2) of Regulation S-K.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have updated the DRS to include quantitative information on appointment growth, pricing disclosure, and revenue. Please see page
    33 and 34.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Business,
    page 38</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    note your reference to your medical advisory committee on page 38. Please provide a brief description of this committee, including
    its role in the company, responsibilities and composition.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have updated the DRS on page 35 to include a more robust description of the medical advisory committee. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    revise the graphics throughout the DRS to ensure that it is of high enough resolution and type size that all information is legible.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have updated the DRS to include a higher resolution version of this graphic. Please see page 36.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    revise your disclosure to discuss the material terms of your Business Associate Agreements with local healthcare clinics, manufacturers
    and vendors, including the vendors that review the predictions and inferences made by your AI. Ensure you include the rights and
    obligations of the parties, any payment terms, duration, and termination provisions. Please also file these agreements as exhibits
    to your registration statement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have updated the disclosure per your request in the section &ldquo;Product Affiliate Agreements&rdquo; on page 32, and
    added a form of Business Associate Agreement as Exhibit 10.6.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Retail
    Sales of Dietary Supplements and Products, page 42</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    expand your disclosure with regard to your retail sales to describe each of your three gummy products, including how you supply and
    manufacture these products, and the government regulations or approvals that affect your ability to offer these products. Further,
    please revise the description of your products to avoid referring to any CBD products as supplements, which implies that these products
    supplement diet or nutrition. For guidance, please refer to Question 9 of the FDA&rsquo;s Regulation of Cannabis and Cannabis-Derived
    Products: Questions and Answers (available at https://www.fda.gov/news-events/public-health-focus/fda-regulation- cannabis-and- cannabis-derived-products-including-cannabidiol-cbd).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    Thank you for your comment. We have updated the description of our gummy products on page 39 of the DRS and have removed all
    references to &ldquo;supplements&rdquo; throughout the document.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Our
    Competitive Strengths, page 42</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    note that KindlyMD offers telehealth online to patients in select markets. Please identify those markets and discuss the effect of
    telehealth regulations on your business. In your Government Regulation section and the related risk factor section, please revise
    to discuss briefly state regulation of telehealth in those jurisdictions and their effect on your business.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have updated the DRS to address this comment. Please see page 39 and 41 of the amended DRS.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Government
    Regulation, page 44</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    revise this section to provide a more detailed discussion regarding the effect of existing or probable governmental regulations on
    the business. Discussions should include, but are not limited to, regulation related to telehealth and telepsychology provider licensing,
    medical practice, psychology, certification and related laws and guidelines, corporate practice of medicine laws, fee splitting,
    cyber security, patient confidentiality, insurance regulation (if any), and any other relevant regulations you believe are applicable
    to your line of business.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have updated the DRS based on this comment. Please see page 5 and 42 of the amendment.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    note your intention to expand your operations into four other states. Please expand your government regulation section to discuss
    the cannabis regulations, including the licensure and registration requirements, you must satisfy to operate in those states, including
    the steps you have taken to satisfy those requirements and the steps that remain. Please also consider inserting risk factor disclosure
    related to these regulations and the consequences of failing to comply. Also expand on your risk factors related to the medical marijuana
    industry on page 12. If you do not believe that these regulations apply to your products and services, provide us an analysis with
    support to explain your conclusions.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have updated the DRS based on this comment. Please see pages 11 and 42 of the amendment.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Management,
    page 45</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    revise Messrs. Cox and Barrera&rsquo;s biographies to discuss their principal occupation and employment for the past five years,
    including the name, and principal business of any corporation or other organization. Please also indicate any other directorships
    held during the last five years for each director. See Item 401(e) of Regulation S-K.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have updated the executive biographies per your request on page 43 of the DRS.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Executive
    Compensation, page 50</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    update your executive compensation table for the fiscal year ended December 31, 2022. Please also include the executive compensation
    of the company&rsquo;s two most highly compensated executive officers other than the chief executive officer who were serving as
    executive officers at the end of December 31, 2022, and an outstanding equity awards table. Refer to Item 402(m) and (p) of Regulation
    S-K.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have updated the executive compensation table per your request. Please see page 47 of the DRS.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    provide a footnote explanation to include identification to the extent material for any item included under &ldquo;All Other Compensation&rdquo;.
    See Item 402(o)(7) of Regulation S- K.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have updated the footnotes to the Executive Compensation table per your request on page 47.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    note your consulting agreement with Wade Rivers, LLC, which is owned and managed by Tim Pickett, and your footnote (b), which states
    that Mr. Pickett&rsquo;s compensation includes the amounts paid to a related entity. Please revise your footnote disclosure to clarify
    the amount of compensation paid to Mr. Pickett and the amount paid to Wade River, LLC.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have updated the footnotes to the Executive Compensation table per your request.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Item
    15: Recent Sales of Unregistered Securities, page II-2</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    disclose the nature and the amount of consideration paid for the shares issued in your disclosed private placement transactions.
    See Item 701(c) of Regulation S-K.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have updated the disclosure per your request. </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>General</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    ensure each exhibit is in the proper text-searchable format. See Rules 301 and 304 of Regulation S-T. For example, we note Exhibits
    3.4, 10.1, 10.4 and 10.5.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have updated the Exhibits per your request on page II-2.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    note that your exclusive forum provision in Section 11.01 of your corporate bylaws identifies the state and federal courts located
    within Salt Lake County, Utah as the exclusive forum for certain litigation, including any &ldquo;derivative action.&rdquo; Please
    disclose whether this provision applies to actions arising under the Securities Act or Exchange Act. In that regard, we note that
    Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created
    by the Exchange Act or the rules and regulations thereunder, and Section 22 of the Securities Act creates concurrent jurisdiction
    for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and
    regulations thereunder. If the provision applies to Securities Act claims, please also revise your prospectus to state that there
    is uncertainty as to whether a court would enforce such provision and that investors cannot waive compliance with the federal securities
    laws and the rules and regulations thereunder. If this provision does not apply to actions arising under the Securities Act or Exchange
    Act, please also ensure that the exclusive forum provision in the governing documents states this clearly, or tell us how you will
    inform investors in future filings that the provision does not apply to any actions arising under the Securities Act or Exchange
    Act.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We have amended our corporate bylaws to eliminate this conflict and have filed the Restated Bylaws as Exhibit 3.6.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
    supplementally provide us with copies of all written communications, as defined in Rule 405 under the Securities Act, that you, or
    anyone authorized to do so on your behalf, present to potential investors in reliance on Section 5(d) of the Securities Act, whether
    or not they retain copies of the communications.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Response:
    We will provide you with all written communications in reliance on Section 5(d) of the Securities Act, if and when such communications
    occur. To date, no such communications have occurred.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.15pt 0pt 5.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thank
you for your assistance and review; we look forward to resolving any further comments or questions. Please reach out to our legal counsel,
Callie Jones, at (801)303-5721 with any additional comments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Kindly
    MD, Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Tim Pickett</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tim
    Pickett </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" !Q ?0# 2(  A$! Q$!_\0
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M=!0 ]6//U]::S'CZ>M*IZ\#K36YQP.E "ACN_P#KTK,<'_&D!^?H*&/!X%
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M)^J/HDGCH?SIR\C^+I7S3IW_  6%_9BU>Y\J'XW>!-_3#WOEC\V %>N?#/\
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M'[ _Q?88./"M]U&?^69K^4F.SCDTZ,87:T8&-O&=OI7]6G_!263=^P+\8O\
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M;'&UAR/Q-?MA_P $#?\ @H+XH_;S_9Y\877CS5(=6\8>&O$,L=W)%$(H5@F
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M5R]C\X;'_@U^_9LM=;-Q*?'EY9[]WV*37'$)QV) W8_&OM#]F7]DSX??L=>
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M/\F@I\K<]_6B-/?]: !U&/Q]:-HW_CZT.G'7OZT;/GZ]_6@!VT?KZTW:-_\
M]>G;/?OZTW9\_7]: !5&1_C0ZC/_ ->A4Y'/ZT.G/7]: %VC*_XTA4;?P'>E
MV<KS^M(4^7KV'>@ =1G_ .O2E1L_^O2.G/7]:4I\G7]: $VC#?XTH48_^O2;
M.&Y_6E"<=?UH 1U&/Q]: HX^OK0Z<=>_K0$Z<]_6@!P48_\ KTP*,_\ UZ>$
MXZ_K343YNOZT ($X_&F/%N4YYW=LU,J=>>_K363ISV]: ]3A_&'[-7P_^(FJ
M+?:_X(\):U?#D3WNE03R?]],I-=5I_A^UT73XK6QM[>SMK= D4,*!$B X 4#
M@?E5X)\W7]:5DX//ZU7,]C*%"G!\T(I,9#%Y:!6Z_7K4@48_^O363YNO;UIP
M3CK^M2:C749_#UIRJ.?KZTUTYZ]O6G*G7GOZT #*./KZTT*-G_UZ<R=.>_K3
M0GR=?UH <%&?_KTS:,?_ %Z>$YZ_K3-G'7]: %11C\?6G;1O_#UIJ)QU[^M.
MV?/U[>M #44;O_KTYE'Z>M-1/FZ_K3F3W[>M #"HQ_\ 7IVT8_#UII3CK^M.
MV<=>WK0 CJ/\FAE&3_C0Z>_ZT,G)Y_6@!748_P#KT@4;/_KTKIQU_6D"?)U_
M6@!P49_^O10$YZ_K10 [N/QI/X_QHHH 5NM'9:** &G[_P"% Z445,B8[D<O
M7\*='T:BBM.AJ]A$^]3_ .$_A1101V*\?_'Q^-._Y>:**T(Q6R')_P ?AJ5?
MZT45G(UD/IO?\Z**DD<.E-?K^%%% !W6@_<HHH :>E/7^E%% "'[K?6B.BB@
M ?I^-)_'^-%% #O\:3^.BB@ 7J*'ZT44 '=:#]W\!110 /UH/W*** #LU Z4
M44 #]/QI!V^M%% #QTIB?>HHH <O?ZTUNWTHHH 4?>H;H:** !OO?A3ATHHH
M :_7\*5>_P!:** !NWUI!]RBB@!PZU'VHHH <G3\:7^/\*** &I]ZG-_2BB@
>!AZ4[M^%%%  ]#=3110 /TH'W*** '#K1110!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
